We are delighted to announce the renewal of our partnership with Menarini Group, that will be joining us as a Gold Sponsor for Frontiers Health 2024. This collaboration underscores our shared commitment to advancing healthcare innovation and improving patient outcomes.

The Menarini Group is a leading international pharmaceutical and diagnostics company, with a turnover of $4.7 billion and over 17,000 employees. Menarini is focused on therapeutic areas with high unmet needs with products for cardiology, oncology, pneumology, gastroenterology, infectious diseases, diabetology, inflammation, and analgesia. With 18 production sites and 9 Research and Development centers, Menarini’s products are available in 140 countries worldwide. 

This partnership demonstrates Menarini's unwavering commitment to digital health innovation in the biopharmaceutical industry. By empowering its workforce with cutting-edge digital health knowledge, Menarini is better equipped to deliver exceptional service to its customers. Dr. Steven Januar Kusmanto, MM (Global Director, Digital & Customer Engagement) and Davide Covello, (Global Digital, Customer Engagement & Omnichannel Manager), affirm, "This collaboration aligns with our vision, serves as a catalyst for holistic transformation focusing on upskilling our people and harnessing the potential of digital innovation to anticipate evolving customer needs and enhance customer experiences." 

Join us at FH24 in Berlin to discover how Menarini Pharmaceutical Group is leading the way in digital transformation!